China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
NEW YORK, April 19, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of NantHealth, Inc. ("NantHealth") (NASDAQ:NH) (1) pursuant and/or traceable to the Company’s initial public offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017. You are hereby notified that Levi & Korsinsky has commenced the securities class action lawsuit Shafik v. NantHealth, Inc., et al. (Case No. 2:17-cv-01940-DMG-SS) in the USDC for the Central District of California. To get more information go to:
http://www.zlk.com/pslra/nanthealth-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose: (1) that Company founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; (2) that, as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability; (3) that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and (4) that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016.
If you suffered a loss in NantHealth you have until May 8, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
